To increase amounts authorized and appropriated for commitments for the Paycheck Protection Program authorized under section 7(a) of the Small Business Act, economic injury disaster loans and emergency grants under the CARES Act, to fund hospital and provider recovery and testing, and for other purposes.

SA 1580. Mr. McCONNELL (for himself and Mr. Schumer) proposed an
amendment to the bill H.R. 266, making appropriations for the
Department of the Interior, environment, and related agencies for the
fiscal year ending September 30, 2019, and for other purposes; as
follows:

Strike all after the enacting clause and insert the
following:

SECTION 1. SHORT TITLE.

This Act may be cited as the ``Paycheck Protection Program
and Health Care Enhancement Act''.

SEC. 2. TABLE OF CONTENTS.

The table of contents for this Act is as follows:

Sec. 1. Short title.
Sec. 2. Table of contents.
Sec. 3. References.

DIVISION A--SMALL BUSINESS PROGRAMS

Sec. 101. Amendments to the Paycheck Protection Program, economic
injury disaster loans, and emergency grants.
Sec. 102. Emergency designation.

DIVISION B--ADDITIONAL EMERGENCY APPROPRIATIONS FOR CORONAVIRUS
RESPONSE

SEC. 3. REFERENCES.

Except as expressly provided otherwise, any reference to
``this Act'' contained in any division of this Act shall be
treated as referring only to the provisions of that division.

DIVISION A--SMALL BUSINESS PROGRAMS

SEC. 101. AMENDMENTS TO THE PAYCHECK PROTECTION PROGRAM,
ECONOMIC INJURY DISASTER LOANS, AND EMERGENCY
GRANTS.

(a) Increased Authority for Commitments and Appropriations
for Paycheck Protection Program.--Title I of division A of
the Coronavirus Aid, Relief, and Economic Security Act
(Public Law 116-136) is amended--
(1) in section 1102(b)(1), by striking ``$349,000,000,000''
and inserting ``$659,000,000,000''; and
(2) in section 1107(a)(1), by striking ``$349,000,000,000''
and inserting ``$670,335,000,000''.
(b) Increased Authorization for Emergency EIDL Grants.--
Section 1110(e)(7) of division A of the Coronavirus Aid,
Relief, and Economic Security Act (Public Law 116-136) is
amended by striking ``$10,000,000,000'' and inserting
``$20,000,000,000''.
(c) Eligibility of Agricultural Enterprises for Economic
Injury Disaster Loans and Emergency Grants.--Section
1110(a)(2) of division A of the Coronavirus Aid, Relief, and
Economic Security Act (Public Law 116-136) is amended--
(1) in subparagraph (D), by striking ``or'' at the end;
(2) in subparagraph (E), by striking the period at the end
and inserting ``; or''; and
(3) by adding at the end the following:
``(F) an agricultural enterprise (as defined in section
18(b) of the Small Business Act (15 U.S.C. 647(b)) with not
more than 500 employees.''.
(d) Set Aside for Insured Depository Institutions, Credit
Unions, and Community Financial Institutions.--Section
7(a)(36) of the Small Business Act (15 U.S.C. 636(a)(36)) is
amended--
(1) in subparagraph (A)--
(A) in clause (viii), by striking ``and'' at the end;
(B) in clause (ix), by striking the period at the end and
inserting a semicolon; and
(C) by adding at the end the following:
``(x) the term `community development financial
institution' has the meaning given the term in section 103 of
the Riegle Community Development and Regulatory Improvement
Act of 1994 (12 U.S.C. 4702));
``(xi) the term `community financial institutions' means--

``(I) a community development financial institution;
``(II) a minority depository institution, as defined in
section 308 of the Financial Institutions Reform, Recovery,
and Enforcement Act of 1989 (12 U.S.C. 1463 note);
``(III) a development company that is certified under title
V of the Small Business Investment Act of 1958 (15 U.S.C. 695
et seq.); and
``(IV) an intermediary, as defined in section 7(m)(11); and

``(xii) the term `credit union' means a State credit union
or a Federal credit union, as those terms are defined,
respectively, in section 101 of the Federal Credit Union Act
(12 U.S.C. 1752).''; and
(2) by adding at the end the following:
``(S) Set-aside for insured depository institutions, credit
unions, and community financial institutions.--
``(i) Insured depository institutions and credit unions.--
In making loan guarantees under this paragraph after the date
of enactment of this clause, the Administrator shall
guarantee not less than $30,000,000,000 in loans made by--

``(I) insured depository institutions with consolidated
assets of not less than $10,000,000,000 and less than
$50,000,000,000; and
``(II) credit unions with consolidated assets of not less
than $10,000,000,000 and less than $50,000,000,000.

``(ii) Community financial institutions, small insured
depository institutions, and credit unions.--In making loan
guarantees under this paragraph after the date of enactment
of this clause, the Administrator shall

[[Page S2218]]

guarantee not less than $30,000,000,000 in loans made by--

``(I) community financial institutions;
``(II) insured depository institutions with consolidated
assets of less than $10,000,000,000; and
``(III) credit unions with consolidated assets of less than
$10,000,000,000.''.

SEC. 102. EMERGENCY DESIGNATION.

(a) In General.--The amounts provided under this division
are designated as an emergency requirement pursuant to
section 4(g) of the Statutory Pay-As-You-Go Act of 2010 (2
U.S.C. 933(g)).
(b) Designation in Senate.--In the Senate, this division is
designated as an emergency requirement pursuant to section
4112(a) of H. Con. Res. 71 (115th Congress), the concurrent
resolution on the budget for fiscal year 2018.

DIVISION B--ADDITIONAL EMERGENCY APPROPRIATIONS FOR CORONAVIRUS
RESPONSE

The following sums are hereby appropriated, out of any
money in the Treasury not otherwise appropriated, for the
fiscal year ending September 30, 2020, and for other
purposes, namely:

TITLE I

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary

public health and social services emergency fund

(including transfer of funds)

For an additional amount for ``Public Health and Social
Services Emergency Fund'', $75,000,000,000, to remain
available until expended, to prevent, prepare for, and
respond to coronavirus, domestically or internationally, for
necessary expenses to reimburse, through grants or other
mechanisms, eligible health care providers for health care
related expenses or lost revenues that are attributable to
coronavirus:  Provided, That these funds may not be used to
reimburse expenses or losses that have been reimbursed from
other sources or that other sources are obligated to
reimburse:  Provided further, That recipients of payments
under this paragraph in this Act shall submit reports and
maintain documentation as the Secretary of Health and Human
Services (referred to in this paragraph as the ``Secretary'')
determines are needed to ensure compliance with conditions
that are imposed by this paragraph in this Act for such
payments, and such reports and documentation shall be in such
form, with such content, and in such time as the Secretary
may prescribe for such purpose:  Provided further, That
``eligible health care providers'' means public entities,
Medicare or Medicaid enrolled suppliers and providers, and
such for-profit entities and not-for-profit entities not
otherwise described in this proviso as the Secretary may
specify, within the United States (including territories),
that provide diagnoses, testing, or care for individuals with
possible or actual cases of COVID-19:  Provided further, That
the Secretary shall, on a rolling basis, review applications
and make payments under this paragraph in this Act:  Provided
further, That funds appropriated under this paragraph in this
Act shall be available for building or construction of
temporary structures, leasing of properties, medical supplies
and equipment including personal protective equipment and
testing supplies, increased workforce and trainings,
emergency operation centers, retrofitting facilities, and
surge capacity:  Provided further, That, in this paragraph,
the term ``payment'' means a pre-payment, prospective
payment, or retrospective payment, as determined appropriate
by the Secretary:  Provided further, That payments under this
paragraph in this Act shall be made in consideration of the
most efficient payment systems practicable to provide
emergency payment:  Provided further, That to be eligible for
a payment under this paragraph in this Act, an eligible
health care provider shall submit to the Secretary an
application that includes a statement justifying the need of
the provider for the payment and the eligible health care
provider shall have a valid tax identification number:
Provided further, That, not later than 3 years after final
payments are made under this paragraph in this Act, the
Office of Inspector General of the Department of Health and
Human Services shall transmit a final report on audit
findings with respect to this program to the Committees on
Appropriations of the House of Representatives and the
Senate:  Provided further, That nothing in this paragraph
limits the authority of the Inspector General or the
Comptroller General to conduct audits of interim payments at
an earlier date:  Provided further, That not later than 60
days after the date of enactment of this Act, the Secretary
shall provide a report to the Committees on Appropriations of
the House of Representatives and the Senate on obligation of
funds, including obligations to such eligible health care
providers summarized by State of the payment receipt:
Provided further, That such reports shall be updated and
submitted to such Committees every 60 days until funds are
expended:  Provided further, That such amount is designated
by the Congress as being for an emergency requirement
pursuant to section 251(b)(2)(A)(i) of the Balanced Budget
and Emergency Deficit Control Act of 1985.
For an additional amount for ``Public Health and Social
Services Emergency Fund'', $25,000,000,000, to remain
available until expended, to prevent, prepare for, and
respond to coronavirus, domestically or internationally, for
necessary expenses to research, develop, validate,
manufacture, purchase, administer, and expand capacity for
COVID-19 tests to effectively monitor and suppress COVID-19,
including tests for both active infection and prior exposure,
including molecular, antigen, and serological tests, the
manufacturing, procurement and distribution of tests, testing
equipment and testing supplies, including personal protective
equipment needed for administering tests, the development and
validation of rapid, molecular point-of-care tests, and other
tests, support for workforce, epidemiology, to scale up
academic, commercial, public health, and hospital
laboratories, to conduct surveillance and contact tracing,
support development of COVID-19 testing plans, and other
related activities related to COVID-19 testing:  Provided,
That of the amount appropriated under this paragraph in this
Act, not less than $11,000,000,000 shall be for States,
localities, territories, tribes, tribal organizations, urban
Indian health organizations, or health service providers to
tribes for necessary expenses to develop, purchase,
administer, process, and analyze COVID-19 tests, including
support for workforce, epidemiology, use by employers or in
other settings, scale up of testing by public health,
academic, commercial, and hospital laboratories, and
community-based testing sites, health care facilities, and
other entities engaged in COVID-19 testing, conduct
surveillance, trace contacts, and other related activities
related to COVID-19 testing:  Provided further, That of the
amount identified in the preceding proviso, not less than
$2,000,000,000 shall be allocated to States, localities, and
territories according to the formula that applied to the
Public Health Emergency Preparedness cooperative agreement in
fiscal year 2019, not less than $4,250,000,000 shall be
allocated to States, localities, and territories according to
a formula methodology that is based on relative number of
cases of COVID-19, and not less than $750,000,000 shall be
allocated in coordination with the Director of the Indian
Health Service, to tribes, tribal organizations, urban Indian
health organizations, or health service providers to tribes:
Provided further, That the Secretary of Health and Human
Services (referred to in this paragraph as the ``Secretary'')
may satisfy the funding thresholds outlined in the first and
second provisos under this paragraph in this Act by making
awards through other grant or cooperative agreement
mechanisms:  Provided further, That not later than 30 days
after the date of enactment of this Act, the Governor or
designee of each State, locality, territory, tribe, or tribal
organization receiving funds pursuant to this Act shall
submit to the Secretary its plan for COVID-19 testing,
including goals for the remainder of calendar year 2020, to
include: (1) the number of tests needed, month-by-month, to
include diagnostic, serological, and other tests, as
appropriate; (2) month-by-month estimates of laboratory and
testing capacity, including related to workforce, equipment
and supplies, and available tests; and (3) a description of
how the State, locality, territory, tribe, or tribal
organization will use its resources for testing, including as
it relates to easing any COVID-19 community mitigation
policies:  Provided further, That the Secretary shall submit
such formula methodology identified in the first proviso
under this paragraph in this Act to the Committees on
Appropriations of the House of Representatives and the Senate
one day prior to awarding such funds:  Provided further, That
such funds identified in the first and second provisos under
this paragraph in this Act shall be allocated within 30 days
of the date of enactment of this Act:  Provided further, That
of the amount appropriated under this paragraph in this Act,
not less than $1,000,000,000 shall be transferred to the
``Centers for Disease Control and Prevention--CDC-Wide
Activities and Program Support'' for surveillance,
epidemiology, laboratory capacity expansion, contact tracing,
public health data surveillance and analytics infrastructure
modernization, disseminating information about testing, and
workforce support necessary to expand and improve COVID-19
testing:  Provided further, That of the amount appropriated
under this paragraph in this Act, not less than $306,000,000
shall be transferred to the ``National Institutes of Health--
National Cancer Institute'' to develop, validate, improve,
and implement serological testing and associated technologies
for the purposes specified under this paragraph in this Act:
Provided further, That of the amount appropriated under this
paragraph in this Act, not less than $500,000,000 shall be
transferred to the ``National Institutes of Health--National
Institute of Biomedical Imaging and Bioengineering'' to
accelerate research, development, and implementation of point
of care and other rapid testing related to coronavirus:
Provided further, That of the amount appropriated under this
paragraph in this Act, not less than $1,000,000,000 shall be
transferred to the ``National Institutes of Health--Office of
the Director'' to develop, validate, improve, and implement
testing and associated technologies; to accelerate research,
development, and implementation of point of care and other
rapid testing; and for partnerships with governmental and
non-governmental entities to research, develop, and implement
the activities outlined in this proviso:  Provided further,
That funds in the preceding proviso may be transferred to the
accounts of the Institutes and Centers of the National

[[Page S2219]]

Institutes of Health (referred to in this paragraph as the
``NIH'') for the purposes specified in the preceding proviso:
Provided further, That the transfer authority provided in
the preceding proviso is in addition to all other transfer
authority available to the NIH:  Provided further, That of
the amount appropriated under this paragraph in this Act, not
less than $1,000,000,000 shall be available to the Biomedical
Advanced Research and Development Authority for necessary
expenses of advanced research, development, manufacturing,
production, and purchase of diagnostic, serologic, or other
COVID-19 tests or related supplies, and other activities
related to COVID-19 testing at the discretion of the
Secretary:  Provided further, That of the amount appropriated
under this paragraph in this Act, $22,000,000, shall be
transferred to the ``Department of Health and Human
Services--Food and Drug Administration--Salaries and
Expenses'' to support activities associated with diagnostic,
serological, antigen, and other tests, and related
administrative activities:  Provided further, That the amount
appropriated under this paragraph in this Act may be used for
grants for the rent, lease, purchase, acquisition,
construction, alteration, renovation, or equipping of non-
federally owned facilities to improve preparedness and
response capability at the State and local level for
diagnostic, serologic, or other COVID-19 tests, or related
supplies:  Provided further, That the amount appropriated
under this paragraph in this Act may be used for
construction, alteration, renovation, or equipping of non-
federally owned facilities for the production of diagnostic,
serologic, or other COVID-19 tests, or related supplies,
where the Secretary determines that such a contract is
necessary to secure, or for the production of, sufficient
amounts of such tests or related supplies:  Provided further,
That funds appropriated under this paragraph in this Act may
be used for purchase of medical supplies and equipment,
including personal protective equipment and testing supplies
to be used for administering tests, increased workforce and
trainings, emergency operation centers, and surge capacity
for diagnostic, serologic, or other COVID-19 tests, or
related supplies:  Provided further, That products purchased
with funds appropriated under this paragraph in this Act may,
at the discretion of the Secretary, be deposited in the
Strategic National Stockpile under section 319F-2 of the
Public Health Service Act:  Provided further, That of the
amount appropriated under this paragraph in this Act,
$600,000,000 shall be transferred to ``Health Resources and
Services Administration--Primary Health Care'' for grants
under the Health Centers program, as defined by section 330
of the Public Health Service Act, and for grants to federally
qualified health centers, as defined in section
1861(aa)(4)(B) of the Social Security Act:  Provided further,
That sections 330(e)(6)(A)(iii), 330(e)(6)(B)(iii), and
330(r)(2)(B) of the Public Health Service Act shall not apply
to funds provided under the previous proviso:  Provided
further, That of the amount appropriated under this paragraph
in this Act, $225,000,000 shall be used to provide additional
funding for COVID-19 testing and related expenses, through
grants or other mechanisms, to rural health clinics as
defined in section 1861(aa)(2) of the Social Security Act,
with such funds also available to such entities for building
or construction of temporary structures, leasing of
properties, and retrofitting facilities as necessary to
support COVID-19 testing:  Provided further, That such funds
shall be distributed using the procedures developed for the
Provider Relief Fund authorized under the third paragraph
under this heading in division B of the Coronavirus Aid,
Relief, and Economic Security Act (Public Law 116-136); may
be distributed using contracts or agreements established for
such program; and shall be subject to the process
requirements applicable to such program:  Provided further,
That the Secretary may specify a minimum amount for each
eligible entity accepting assistance under the two previous
provisos:  Provided further, That up to $1,000,000,000 of
funds provided under this paragraph in this Act may be used
to cover the cost of testing for the uninsured, using the
definitions applicable to funds provided under this heading
in Public Law 116-127:  Provided further, That not later than
21 days after the date of enactment of this Act, the
Secretary, in coordination with other appropriate departments
and agencies, shall issue a report on COVID-19 testing:
Provided further, That such report shall include data on
demographic characteristics, including, in a de-identified
and disaggregated manner, race, ethnicity, age, sex,
geographic region and other relevant factors of individuals
tested for or diagnosed with COVID-19, to the extent such
information is available:  Provided further, That such report
shall include information on the number and rates of cases,
hospitalizations, and deaths as a result of COVID-19:
Provided further, That such report shall be submitted to the
Committees on Appropriations of the House and Senate, and the
Committee on Energy and Commerce of the House of
Representatives and the Committee on Health, Education,
Labor, and Pensions of the Senate, and updated and
resubmitted to such Committees, as necessary, every 30 days
until the end of the COVID-19 public health emergency first
declared by the Secretary on January 31, 2020:  Provided
further, That not later than 180 days after the date of
enactment of this Act, the Secretary shall issue a report on
the number of positive diagnoses, hospitalizations, and
deaths as a result of COVID-19, disaggregated nationally by
race, ethnicity, age, sex, geographic region, and other
relevant factors:  Provided further, That such report shall
include epidemiological analysis of such data:  Provided
further, That not later than 30 days after the date of the
enactment of this Act, the Secretary, in coordination with
other departments and agencies, as appropriate, shall report
to the Committees on Appropriations of the House and Senate,
the Committee on Energy and Commerce of the House of
Representatives, and the Committee on Health, Education,
Labor, and Pensions of the Senate on a COVID-19 strategic
testing plan:  Provided further, That such plan shall assist
States, localities, territories, tribes, tribal
organizations, and urban Indian health organizations, in
understanding COVID-19 testing for both active infection and
prior exposure, including hospital-based testing, high-
complexity laboratory testing, point-of-care testing, mobile-
testing units, testing for employers and other settings, and
other tests as necessary:  Provided further, That such plan
shall include estimates of testing production that account
for new and emerging technologies, as well as guidelines for
testing:  Provided further, That such plan shall address how
the Secretary will increase domestic testing capacity,
including testing supplies; and address disparities in all
communities:  Provided further, That such plan shall outline
Federal resources that are available to support the testing
plans of each State, locality, territory, tribe, tribal
organization, and urban Indian health organization:  Provided
further, That such plan shall be updated every 90 days until
funds are expended:  Provided further, That such amount is
designated by the Congress as being for an emergency
requirement pursuant to section 251(b)(2)(A)(i) of the
Balanced Budget and Emergency Deficit Control Act of 1985.

GENERAL PROVISIONS--THIS TITLE

(including transfer of funds)

Sec. 101.  The requirements, authorities, and conditions
described in sections 18108, 18109, and 18112 of division B
of the Coronavirus Aid, Relief, and Economic Security Act
(Public Law 116-136) shall apply to funds appropriated in
this Act to the Department of Health and Human Services.
Sec. 102.  Funds appropriated by this Act under the heading
``Department of Health and Human Services'', except for the
amounts specified in the first paragraph and the first and
second provisos in the second paragraph under the heading
``Public Health and Social Services Emergency Fund'', may be
transferred to, and merged with, other appropriation accounts
under the headings ``Centers for Disease Control and
Prevention'', ``Public Health and Social Services Emergency
Fund'', ``Food and Drug Administration'', and ``National
Institutes of Health'' to prevent, prepare for, and respond
to coronavirus following consultation with the Office of
Management and Budget:  Provided, That the Committees on
Appropriations of the House of Representatives and the Senate
shall be notified 10 days in advance of any such transfer:
Provided further, That, upon a determination that all or part
of the funds transferred from an appropriation by this Act
are not necessary, such amounts may be transferred back to
that appropriation:  Provided further, That none of the funds
made available by this Act may be transferred pursuant to the
authority in section 205 of division A of Public Law 116-94
or section 241(a) of the Public Health Service Act.
Sec. 103.  Of the funds appropriated by this Act under the
heading ``Public Health and Social Services Emergency Fund'',
up to $6,000,000 shall be transferred to, and merged with,
funds made available under the heading ``Office of the
Secretary, Office of Inspector General'', and shall remain
available until expended, for oversight of activities
supported with funds appropriated to the Department of Health
and Human Services to prevent, prepare for, and respond to
coronavirus, domestically or internationally:  Provided, That
the Inspector General of the Department of Health and Human
Services shall consult with the Committees on Appropriations
of the House of Representatives and the Senate prior to
obligating such funds:  Provided further, That the transfer
authority provided by this section is in addition to any
other transfer authority provided by law.

TITLE II

INDEPENDENT AGENCIES

Small Business Administration

salaries and expenses

For an additional amount for ``Salaries and Expenses'',
$2,100,000,000, to remain available until September 30, 2021,
to prevent, prepare for, and respond to coronavirus,
domestically or internationally:  Provided, That such amount
is designated by the Congress as being for an emergency
requirement pursuant to section 251(b)(2)(A)(i) of the
Balanced Budget and Emergency Deficit Control Act of 1985.

disaster loans program account

For an additional amount for ``Disaster Loans Program
Account'' for the cost of direct loans authorized by section
7(b) of the Small Business Act, $50,000,000,000, to remain
available until expended, to prevent, prepare for, and
respond to coronavirus, domestically or internationally:
Provided, That such amount is designated by the Congress as
being for an emergency requirement pursuant to section
251(b)(2)(A)(i) of the Balanced

[[Page S2220]]

Budget and Emergency Deficit Control Act of 1985.

emergency eidl grants

For an additional amount for ``Emergency EIDL Grants'' for
the cost of emergency EIDL grants authorized by section 1110
of division A of the CARES Act (Public Law 116-136),
$10,000,000,000, to remain available until expended, to
prevent, prepare for, and respond to coronavirus,
domestically or internationally:  Provided, That such amount
is designated by the Congress as being for an emergency
requirement pursuant to section 251(b)(2)(A)(i) of the
Balanced Budget and Emergency Deficit Control Act of 1985.

TITLE III

GENERAL PROVISIONS--THIS ACT

Sec. 301.  Each amount appropriated or made available by
this Act is in addition to amounts otherwise appropriated for
the fiscal year involved.
Sec. 302.  No part of any appropriation contained in this
Act shall remain available for obligation beyond the current
fiscal year unless expressly so provided herein.
Sec. 303.  Unless otherwise provided for by this Act, the
additional amounts appropriated by this Act to appropriations
accounts shall be available under the authorities and
conditions applicable to such appropriations accounts for
fiscal year 2020.
Sec. 304.  Notwithstanding any other provision of law,
funds made available in this Act, or transferred pursuant to
authorization granted in this Act, may only be used to
prevent, prepare for, and respond to coronavirus.
Sec. 305.  In this Act, the term ``coronavirus'' means
SARS-CoV-2 or another coronavirus with pandemic potential.
Sec. 306.  Each amount designated in this Act by the
Congress as being for an emergency requirement pursuant to
section 251(b)(2)(A)(i) of the Balanced Budget and Emergency
Deficit Control Act of 1985 shall be available (or rescinded
or transferred, if applicable) only if the President
subsequently so designates all such amounts and transmits
such designations to the Congress.
Sec. 307.  Any amount appropriated by this Act, designated
by the Congress as an emergency requirement pursuant to
section 251(b)(2)(A)(i) of the Balanced Budget and Emergency
Deficit Control Act of 1985 and subsequently so designated by
the President, and transferred pursuant to transfer
authorities provided by this Act shall retain such
designation.

budgetary effects

Sec. 308. (a) Statutory PAYGO Scorecards.--The budgetary
effects of this division shall not be entered on either PAYGO
scorecard maintained pursuant to section 4(d) of the
Statutory Pay As-You-Go Act of 2010.
(b) Senate PAYGO Scorecards.--The budgetary effects of this
division shall not be entered on any PAYGO scorecard
maintained for purposes of section 4106 of H. Con. Res. 71
(115th Congress).
(c) Classification of Budgetary Effects.--Notwithstanding
Rule 3 of the Budget Scorekeeping Guidelines set forth in the
joint explanatory statement of the committee of conference
accompanying Conference Report 105-217 and section 250(c)(7)
and (c)(8) of the Balanced Budget and Emergency Deficit
Control Act of 1985, the budgetary effects of this division
shall be estimated for purposes of section 251 of such Act.
This division may be cited as the ``Additional Emergency
Appropriations for Coronavirus Response''.

____________________